On Tuesday, Alkermes plc (NASDAQ: ALKS) opened higher 6.69% from the last session, before settling in for the closing price of $26.59. Price fluctuations for ALKS have ranged from $21.75 to $32.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.61% over the last five years. Company’s average yearly earnings per share was noted 82.69% at the time writing. With a float of $158.76 million, this company’s outstanding shares have now reached $166.98 million.
The firm has a total of 2100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 82.31%, operating margin of 20.77%, and the pretax margin is 22.07%.
Alkermes plc (ALKS) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Alkermes plc is 1.88%, while institutional ownership is 110.89%. The most recent insider transaction that took place on Mar 18 ’24, was worth 292,740. In this transaction SVP, Chief Commercial Officer of this company sold 10,417 shares at a rate of $28.10, taking the stock ownership to the 65,911 shares. Before that another transaction happened on Feb 27 ’24, when Company’s VP, Finance (Interim PAO) sold 2,559 for $29.65, making the entire transaction worth $75,874. This insider now owns 7,717 shares in total.
Alkermes plc (ALKS) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 0.22 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.51) by -0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.4 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 82.69% per share during the next fiscal year.
Alkermes plc (NASDAQ: ALKS) Trading Performance Indicators
Check out the current performance indicators for Alkermes plc (ALKS). In the past quarter, the stock posted a quick ratio of 3.03. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.05. Likewise, its price to free cash flow for the trailing twelve months is 14.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.96, a number that is poised to hit 0.75 in the next quarter and is forecasted to reach 1.84 in one year’s time.
Technical Analysis of Alkermes plc (ALKS)
Analysing the last 5-days average volume posted by the [Alkermes plc, ALKS], we can find that recorded value of 1.4 million was lower than the volume posted last year of 1.84 million. As of the previous 9 days, the stock’s Stochastic %D was 53.31%. Additionally, its Average True Range was 0.94.
During the past 100 days, Alkermes plc’s (ALKS) raw stochastic average was set at 83.38%, which indicates a significant decrease from 91.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.94% in the past 14 days, which was higher than the 35.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.61, while its 200-day Moving Average is $26.52. Now, the first resistance to watch is $28.79. This is followed by the second major resistance level at $29.21. The third major resistance level sits at $29.96. If the price goes on to break the first support level at $27.62, it is likely to go to the next support level at $26.87. Should the price break the second support level, the third support level stands at $26.45.
Alkermes plc (NASDAQ: ALKS) Key Stats
There are currently 161,803K shares outstanding in the company with a market cap of 4.59 billion. Presently, the company’s annual sales total 1,663 M according to its annual income of 355,760 K. Last quarter, the company’s sales amounted to 378,140 K and its income totaled 92,380 K.
